Search

everythinglearnresearchcommunity

for

Search:↓

The programme aimed to improve heart health in women with PCOS, but its impact on physical activity was unclear after three months.

Early hair loss may indicate a higher risk of diabetes in young and middle-aged adults.

High homocysteine levels in lupus may increase inflammation and cardiovascular risk.

Nonobese, normotensive Indian women with PCOS may have a higher risk of heart problems linked to inflammation and insulin resistance.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

Women with PCOS face higher risks of diabetes and heart disease, and these risks increase with obesity.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

Premature hair graying may be a sign of increased risk for heart disease, indicating biological age is more important than actual age.

Skin tags in obese individuals may indicate higher cardiovascular risk.

Low dose oral minoxidil can help with hair growth but may cause serious heart problems, so doctors need to be careful.

Skin tags in obese individuals may indicate a higher risk of heart disease and diabetes.

The Princeton III Consensus recommends assessing cardiovascular risk in men with erectile dysfunction and prioritizing heart health before treating ED, especially in those with potential heart disease.

Women with hair loss may have higher heart disease risk.

Rosuvastatin improves lipid levels, reduces inflammation, but worsens insulin sensitivity in men with early-onset hair loss.

Prediabetes may be a risk factor for hair loss.

Severe vertex pattern hair loss may indicate a higher risk for artery plaque buildup.

Androgenetic alopecia may indicate higher risk for certain diseases and mental health issues.

Hyperandrogenism increases heart disease risk in premenopausal women, but this risk is linked to obesity in postmenopausal women.

Insulin resistance increases the risk of developing type 2 diabetes and other health issues.

People with androgenetic alopecia may have a higher risk of peripheral venous disorders.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

People with androgenic alopecia (AGA) have a higher chance of getting metabolic syndrome.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Diagnosing PCOS in teenagers is challenging and should use strict criteria to avoid misdiagnosis and unnecessary worry.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.